Market cap
₹148 Cr
Revenue (TTM)
₹740 Cr
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-11 Cr
-
ROE
-11.6 %
-
ROCE
0.9 %
-
Industry P/E
21.96
-
EV/EBITDA
13.2
-
Debt to Equity
1.4
-
Book Value
₹187.1
-
EPS
₹36.2
-
Face value
10
-
Shares outstanding
23,545,231
10 Years Aggregate
CFO
₹1,226.78 Cr
EBITDA
₹1,017.92 Cr
Net Profit
₹-993.46 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bilcare
| -- | -- | -- | -- | -- | -- | -- |
|
BSE Commodities
| 8.2 | 2.7 | 4.6 | 14.5 | 18.7 | 11.5 | 16.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bilcare
|
62.6 | 148.4 | 739.9 | -40.9 | -1.7 | 18.5 | -- | 0.3 |
| 91.5 | 234.5 | 129.2 | 1.8 | 0.4 | 5.1 | 139.1 | 2.2 | |
| 584.4 | 3,778.0 | 2,665.3 | 351.7 | 15.9 | 15.4 | 10.7 | 1.8 | |
| 799.8 | 2,100.0 | 3,638.7 | 156.0 | 6.8 | 10.2 | 13.5 | 1.3 | |
| 214.7 | 6,882.8 | 4,763.1 | 394.4 | 12.2 | 15 | 17.7 | 2.4 | |
| 691.9 | 3,027.4 | 3,285.2 | -252.8 | -6.6 | -4.9 | -- | 0.8 | |
| 983.9 | 3,086.2 | 6,954.7 | -5.4 | -1.1 | 0.8 | 102 | 0.8 | |
| 174.1 | 632.9 | 680.9 | 28.8 | 6.5 | 10.7 | 22 | 2.3 | |
| 174.6 | 8,621.3 | 5,897.3 | 454.1 | 11.6 | 15 | 19.3 | 2.2 |
Shareholding Pattern
View DetailsNews & Analysis
All News
2 min read•By Jatin Khemani
3 min read•By Research Desk
About Bilcare
Bilcare Limited provides pharmaceutical packaging research solutions and global clinical services in India and internationally. The company offers various specialty polymer films and aluminum foils primarily used for packaging solid dosage... pharmaceutical products; and other packaging films solutions for applications in ID card, specialty film, and food packaging industries. It also provides clinical trial materials supplies and project management services; and nonClonableID, an anti-counterfeiting, security, and brand protection solution for various industry sectors. The company serves pharmaceutical and biotechnology industries. Bilcare Limited was incorporated in 1987 and is based in Pune, India. Read more
-
Incorporated
1987
-
Chairman
Shreyans Bhandari
-
Managing Director
Shreyans Bhandari
-
Group
Caprihans India - MNC
-
Headquarters
Pune, Maharashtra
-
Website
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Bilcare
What is the current share price of Bilcare Ltd Today?
The share price of Bilcare Ltd is ₹62.56 (NSE) and ₹63.01 (BSE) as of 21-May-2026 IST. Bilcare Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Bilcare Ltd?
Since, TTM earnings of Bilcare Ltd is negative, P/E ratio is not available.
The P/B ratio of Bilcare Ltd is 0.34 times as on 21-May-2026, a 84 discount to its peers’ median range of 2.17 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.46
|
|
2024
|
0.00
|
0.27
|
|
2023
|
6.80
|
0.50
|
|
2022
|
0.00
|
2.19
|
|
2021
|
0.00
|
1.57
|
What is the 52 Week High and Low of Bilcare Ltd?
The 52-week high and low of Bilcare Ltd are Rs 75.00 and Rs 51.62 as of 22-May-2026.
What is the market cap of Bilcare Ltd?
Bilcare Ltd has a market capitalisation of ₹ 148 Cr as on 21-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Bilcare Ltd?
Before investing in Bilcare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.